Drug class
Non-fluorinated quinolone antibacterial; topical DNA gyrase and topoisomerase IV inhibitor
Mechanism of action
Inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and repair, producing bactericidal activity against susceptible skin pathogens including Staphylococcus aureus and Streptococcus pyogenes.
General use cases
- Topical treatment of impetigo due to susceptible Staphylococcus aureus or Streptococcus pyogenes in adults and paediatric patients aged 2 months and older under the US product indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
